Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04535362Phase 1Completed
Phase 1, randomised, open-label trial (2 arms), sponsored by Yale University. Primary endpoints: Drug Effect Questionnaire - Stimulatory Effects at 2 weeks, Drug Effect Questionnaire - Pleasure Effect at 2 weeks and 2 more. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04535362.